Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Stuver R, Horwitz SM, Advani RH, Vose JM, Lee HJ, Mehta-Shah N, Zain JM, Haverkos B, Lechowicz MJ, Moskowitz AJ, Pham LQ, Leyden E, Ansell SM, Lunning MA.
Stuver R, et al. Among authors: pham lq.
Br J Haematol. 2023 Aug;202(3):525-529. doi: 10.1111/bjh.18885. Epub 2023 May 22.
Br J Haematol. 2023.
PMID: 37217196
Clinical Trial.